Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Katrina M Wyatt a Academic Department of Obstetrics and
Gynaecology, North Staffordshire Hospital, Stoke on Trent ST4 6QG, b Department of
Mathematics, Keele University, Keele ST5 5BG
Correspondence to: Dr Wyatt
mea10{at}keele.ac.uk
Objective:
To evaluate the efficacy of
vitamin B-6 in the treatment of premenstrual syndrome.
Design:
Systematic review of published and unpublished randomised placebo controlled trials of the effectiveness of vitamin B-6 in the management of premenstrual syndrome.
Subjects:
Nine published trials representing 940 patients with premenstrual syndrome.
Main outcome measures:
Proportion of women whose
overall premenstrual symptoms showed an improvement over placebo. A
secondary analysis was performed on the proportion of women whose
premenstrual depressive symptoms showed an improvement over placebo.
Results:
Odds ratio relative to placebo for an
improvement in overall premenstrual symptoms was 2.32 (95% confidence
interval 1.95 to 2.54). Odds ratio relative to placebo for an
improvement in depressive symptoms was 1.69 (1.39 to 2.06) from four
trials representing 541 patients.
Conclusion:
Conclusions are limited by the
low quality of most of the trials included. Results suggest that doses
of vitamin B-6 up to 100 mg/day are likely to be of benefit in treating premenstrual symptoms and premenstrual depression.
Key messages
Read all Rapid Responses